|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||8.91 - 10.67|
|52-week range||8.91 - 10.67|
|Beta (5Y monthly)||0.94|
|PE ratio (TTM)||0.03|
|Earnings date||26 Apr 2023 - 01 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Emergent Biosolutions (EBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Shares of Emergent BioSolutions (NYSE: EBS) were sinking 12.8% lower as of 10:53 a.m. ET on Friday. Fye also slashed the 12-month price target for Emergent BioSolutions from $23 to $9. Emergent BioSolutions certainly faces some challenges, though, that could justify investors' caution.
Emergent BioSolutions ( NYSE:EBS ) Full Year 2022 Results Key Financial Results Revenue: US$1.12b (down 38% from FY...